In May, U.S.-based Abbott Labs secured the top spot in India’s growing pharmaceutical industry with its US$ billion takeover of Piramal. In , Ajay Piramal promoted Piramal Healthcare sold off its main formulation business to Abbott India for over INR 17, crore and announced a buy-back of . When US-based global health care major Abbott acquired the formulations business of Piramal Healthcare in a $billion deal in , it had.

Author: Kagasida Kazidal
Country: Luxembourg
Language: English (Spanish)
Genre: Health and Food
Published (Last): 10 March 2016
Pages: 165
PDF File Size: 13.90 Mb
ePub File Size: 10.51 Mb
ISBN: 179-6-79743-916-7
Downloads: 7070
Price: Free* [*Free Regsitration Required]
Uploader: Mikazuru

On top of that, India is a growing market.

Abbott To Acquire Piramal Healthcare Unit For $3.72B

Help us delete comments that do not follow these guidelines by marking them offensive. Unlike other pharmaceutical acquisitions that have been targeted at buying Indian generic capacity to service Western and emerging markets, the Abbott-Piramal deal is primarily focused on the domestic market, according to Mumbai-based business magazine Business India.

Infibeam calls off pact to acquire Snapdeal unit Unicommerce. Industry forecaster IMS Health predicts leading emerging markets will show annual pharmaceuticals sales growth of 14 to 17 percent throughagainst just 3 to 6 percent a year for developed markets.

A ‘Bigger Foothold’: What Does the Abbott-Piramal Deal Mean for Indian Pharma? – [email protected]

Abbott said it was advised by Morgan Stanley, while Piramal said it did not have a financial advisor on the deal. The combination of popular brands, strong distribution channel, and US FDA-approved manufacturing plants will give an upperhand to Abbott through the deal.


Three main businesses remained immediately after divestiture was: Featured Today In Travel. Evergrande Group’s Sea Venice real estate project has attracted hordes of buyers in China’s leisure property market. Thank you for your comment, we value your opinion and the time you took to write to us!

Related Videos ET Now: Since then, further pharmaceutical deals have been expected, as global majors search for growth and low-cost production of generics, as patents on major branded drugs are set to expire.

Five years after Abbott deal, Piramal Enterprises delivers stellar growth

Disagreements over valuation have prevented more deals from getting done. Why managers should reveal their failures. Mumbai-based Piramal said it would consider paying a special dividend and would use deal proceeds to invest in its remaining businesses and pay down debt.

Sensex finishes year above 36, posts third straight annual gain. The sale will also involve the transfer of the employees of the domestic formulations business. Piramal’s Healthcare Solutions business employs over 5, people in India. That is one reason pharmaceutical multinationals are doing deals with the relatively small number of well established Indian companies that have met international standards in piramaal.

But the deal takes them to the number one slot, he adds.

The 10 big questions for – Dral 2. Danzon adds that the emerging business plan for generics companies is essentially around selling to pharmacists, not physicians. Food and Drug Administration said in February Ranbaxy sold misbranded or adulterated drugs in the United States, its largest market, having earlier banned agbott of over 30 generic drugs from the firm. This is the 2nd-largest deal ever in the Indian pharma industry, just behind Daiichi Sankyo’s takeover of Ranbaxy in The assets to be transferred include the company’s manufacturing planst in Baddi, Himachal pradesh and rights to approximately brands and trademarks.


Its other businesses include third-party manufacturing and pathology laboratories. L as possible buyers. The earlier regime recognized patents on pharmaceutical processes but not on pharmaceutical products, allowing companies to reverse-engineer copies of the branded and patented drugs of western companies. It allows Abbott to commercialize two dozen Zydus Cadila drugs in 15 emerging markets. It also has a strong presence piramql the OTC segment in India.

Folder Title Folder Description Save. Think Live Work Play. To verify, just follow the link in the message. Your guide to choosing the best books on business. InPiramal Enterprises Ltd. BOthe U. Fortunately for me, there are plenty of those in Asia at the moment. Log feal Keep me signed in.